Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy

In the past few decades, immunotherapy has emerged as one of the most promising strategies among current treatments of cancer. In particular, the field of PD1/PD-L1 inhibitors has been boosted, widely applied into clinical practice with potent therapeutic efficacy and remarkable survival benefits on...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Yuqing Zhou, Zhaoxia Liu, Tingtao Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Subjects:	cancer immunotherapy PD1/PD-L1 gut microbiome probiotics
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.847350/full